Login

Thomas Peterffy, founder and chairman of Interactive Brokers, discusses key topics in an interview with CNBC. 00:10:00

Share On Facebook Share On Twitter

Thomas Peterffy, founder and chairman of Interactive Brokers

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Invests globally and has offices in California, Israel, India, and China|Lip-Bu Tan,Founding Managing Partner,Celesta (fka WRVI)
00:10:00
Brookside Equity's Ray Weldon Collaborates with GLG to Revolutionize Middle-Market Investment Strategies|Raymond F. Weldon ,MD,Brookside Equity Partners
00:10:00
CSE Global T.V. | Lim Boon Kheng, CEO, CSE Global Ltd 544:SES
00:10:00
Challenges and Innovations in Residential Solar and Battery Services | John Berger, CEO , Sunnova Energy International Inc.
00:10:00
Oscar Oberg: Navigating the Future of Small and Micro-Cap Investments
00:10:00
synthesize engineering with physical and life sciences to create technologies that disrupt global conventions|Benjamin Quiroga,General Partner,Humboldt Fund
00:10:00
"Richard Jeffrey, CIO of Cazenove Capital Management Ltd., shares insights on the euro's outlook."
00:10:00
Alberta Firm ClearFlow Develops Portable Solution for Cleaning Oil Industry Wastewater
00:10:00
Jindalee Expands Portfolio with 80% Stake in Deep Well Nickel-Copper-PGE Project
00:10:00
A Differentiated Approach to Traditional Asset Classes|Ari Sass,President,MD Sass Investors Services
00:10:00
Leadership and Success: Insights from Morgan Stanley's Chief Executive Officer on The David Rubenstein Show
00:10:00
Navigating the Challenges: Financial Planning for the Sandwich Generation

© 2026 Nehu